Fig. 2From: Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMTCumulative incidence of non-relapse mortality according to donor typeBack to article page